Will FDA speed up 'path' to treatments?
Bennett holds Salt Lake hearing that focuses on concepts, cures
Sen. Bob Bennett, R-Utah, held a field hearing of the Senate Appropriations Committee at the University of Utah Friday, bringing academics, doctors and government leaders together to discuss the FDA's "Critical Path Initiative."
"We are on the verge of the most profound transformation in the history of medicine," Von Eschenbach said. The medicine of the future "will look no more like the past than a butterfly looks like a caterpillar. It's that profound."
The new frontier looks at genetics as one tool to make people well or even prevent disease. It makes personalized medicine a realistic expectation, according to Dr. David Jones, senior director for early translational research in the Huntsman Cancer Institute.
Critical Pathway takes a drug or medical device from concept to cure, using applied science to help predict and test product safety and effectiveness, as well as who is most likely to respond to the treatment. Genetics and therapeutics are wed in a step toward personalized medicine and, Von Eschenbach said, it should shorten development time and cost.
The initiative is driven in part by a significant and unwelcome decline in new medical products. The road to FDA approval is cumbersome and costly, Bennett said. The goal is to use bioinformation, technology and good ideas to get better treatments to patients in much less time.
They discussed a lung cancer drug found to be so effective for some that they moved from their deathbeds to periods of recovery. But it helped only 10 percent of those who used it. Researchers identified common traits for that 10 percent and developed a genetics test that could help with treatment decisions, but many insurance companies balked at the $500 cost. So some doctors prescribe it at $2,500 a month to all their lung cancer patients, 90 percent of whom gain nothing. Genetic testing would tell them who is most likely to benefit from it.
There are challenges to genetic testing, including fears about confidentiality. Most people don't want their insurance companies and employers to know about their potential to develop a disease in the future, Bennett said.
Dr. Raymond L. Woosley, CEO of the Critical Path Institute, says it costs a fortune to bring drugs from idea to store shelves. The failure rate has doubled. And as many as 4 percent of drugs that make it are later pulled.
Vioxx is an example. As many as 6 percent of patients had serious complications. The other 94 percent didn't. But because no one can predict who those 6 percent will be, the drug was pulled. Improving methods of testing to determine individual traits would bring a drug like Vioxx back to those it helped, while not subjecting those it hurt to the ill effects.
Comments
- 16 killed in Somalia 9:23 a.m.
- Mass funeral for massacre victims 9:22 a.m.
- Obama: 'Africa not separate' 9:20 a.m.
- Former cop seeks parole 9:17 a.m.
- 5 hurt in latest Pamplona bull run 8:49 a.m.
- Delay in Jackson guardianship case 8:47 a.m.
- Attempted murder case refiled 1:58 a.m.
- Sports on the air 1:38 a.m.
- This weekend on TV 1:38 a.m.
- Birthdays for Saturday, July 11 1:38 a.m.
- Jazz brass debate Millsap match
- LDS seminary principal arrested
- 2 men cited on LDS plaza
- HBO defends U. logo use in 'Love'
- Jazz finances not quite so bleak
- Reactions on Boozer speculation
- Cash for Clunkers to get rolling soon
- Utahns among Texans' investors
- Teacher faces new sex charges
- Man spots his stolen car
- LDS seminary principal arrested
183 - Bronco collecting a galaxy of recruits
141 - Jazz talking Boozer trade?
137 - Blazers may offer Millsap a contract
123 - Jazz brass debate Millsap match
114 - Stadium of Fire flag burning was fake
94 - Fairness of BCS debated
81 - Chaffetz eyes challenging Bennett
75 - Letters: Single-payer system best
72 - Services bids farewell to Jackson
70
As more and more dads are put out of work in this economy, I've been...
The photographs are mysterious, brooding, dark. They show dimples and...
I feel sorry for the poor Chinese people. They have suffered so much from...
I guess the saints are like everyone else after all. Hmmmmmmmm. Now that is...
I think both Rigby and Cook need to be dealt with. This case shows if you get...
i spent over a year in iraq with the military, and you know what? even in a...
how many people are playing the "devil's advocate". Even more disgusting is...
It frightens me that so many young people are remembering this man as a...
If it was truly just a peck on the cheek, I'd say no big deal. If they were...
Millsap should not worth 9M and witht he front loaded bonus, I think Jazz may...
So if things are so rosy at Sleepy, why did they just let go the head pro?
The poor are heading south to the Mexican border, perhaps then the State of...


You can be the first to comment on this story.